Learn about clinical trials for Ductal Carcinoma In Situ (DCIS) in this 33-minute medical conference presentation from the Dana-Farber Cancer Institute's third annual Ductal Carcinoma In Situ Patient Forum. Discover current research opportunities and treatment options as Dr. Tari King and Dr. Elizabeth Mittendorf, co-directors of the DCIS Program, provide expert insights into ongoing clinical trials specifically designed for DCIS patients. Gain understanding of how clinical trials work, eligibility criteria, potential benefits and risks, and how these research studies are advancing treatment approaches for this early form of breast cancer. Explore the latest developments in DCIS research and learn how participation in clinical trials can contribute to improving outcomes for current and future patients with this condition.